Company intelligence / Profile preview

Glendevon Life Sciences

Short Hills, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Glendevon Life Sciences is a life sciences consulting and venture formation firm associated with founder Edward Rosen. Public descriptions indicate the firm supports market and technology assessment engagements, helps commercialize novel intellectual property, and is active in establishing new biotechnology companies. Its strategy has been described as bridging academic research and Series A investment through exclusive licensing of early-stage life science IP and provision of management support to portfolio companies. The firm appears to operate more as a life science commercialization, company creation, and investment platform than as a single-product therapeutics developer with a disclosed proprietary clinical pipeline.

Industry: Consulting

Partnerships

Columbia Technology Ventures

Beyond the preview

Go deeper on Glendevon Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glendevon Life Sciences.

Explore the full profile